Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
123,180,519
-
Total 13F shares
-
22,164,659
-
Share change
-
+11,829,679
-
Total reported value
-
$56,076,420
-
Put/Call ratio
-
1.3%
-
Price per share
-
$2.53
-
Number of holders
-
45
-
Value change
-
+$29,949,473
-
Number of buys
-
28
-
Number of sells
-
7
Institutional Holders of CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) as of Q2 2014
As of 30 Jun 2014,
CATALYST PHARMACEUTICALS, INC. - COMMON STOCK (CPRX) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,164,659 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, FRANKLIN RESOURCES INC, Broadfin Capital, LLC, BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, Visium Asset Management, LP, PERCEPTIVE ADVISORS LLC, Opaleye Management Inc., and Catalyst Capital Advisors LLC.
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.